Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody.
ADCC
CDC
EGFR
antitumor activity
canine fibroblastic tumor
monoclonal antibody
Journal
Monoclonal antibodies in immunodiagnosis and immunotherapy
ISSN: 2167-9436
Titre abrégé: Monoclon Antib Immunodiagn Immunother
Pays: United States
ID NLM: 101590955
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
pubmed:
5
4
2022
medline:
29
4
2022
entrez:
4
4
2022
Statut:
ppublish
Résumé
The epidermal growth factor receptor (EGFR) is involved in tumor malignancy through gene amplification and/or protein overexpression. An anti-human EGFR (hEGFR) monoclonal antibody (clone EMab-134), which explicitly detects hEGFR and dog EGFR (dEGFR), was previously developed. The defucosylated mouse IgG
Identifiants
pubmed: 35377239
doi: 10.1089/mab.2021.0059
doi:
Substances chimiques
Antibodies, Monoclonal
0
Antineoplastic Agents
0
ErbB Receptors
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM